Medical treatment of essential tremor and Parkinson's disease

Geriatrics

Volumn 53, Issue 5, 1998, Pages 46-57

  Uitti, Ryan J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; AMANTADINE; ANTICONVULSIVE AGENT; BENZATROPINE MESILATE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BROMOCRIPTINE MESILATE; CARBIDOPA PLUS LEVODOPA; CARBONATE DEHYDRATASE INHIBITOR; CATECHOL METHYLTRANSFERASE INHIBITOR; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; GABAPENTIN; LEVODOPA; LORAZEPAM; METHAZOLAMIDE; PERGOLIDE MESILATE; PRAMIPEXOLE; PRIMIDONE; PROPRANOLOL; ROPINIROLE; SELEGILINE; TIMOLOL MALEATE; TOLCAPONE; TRIHEXYPHENIDYL; UNINDEXED DRUG;

AGITATION; CONFUSION; DIET RESTRICTION; DISABILITY; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG COST; DYSKINESIA; ESSENTIAL TREMOR; HALLUCINATION; HUMAN; ON OFF PHENOMENON; PARKINSON DISEASE; PREVALENCE; REVIEW;

ADRENERGIC BETA-ANTAGONISTS; ANTICONVULSANTS; ANTIPARKINSON AGENTS; CATECHOL O-METHYLTRANSFERASE; CHOLINERGIC ANTAGONISTS; DECISION TREES; DOPAMINE AGONISTS; HUMANS; PARKINSON DISEASE; TREMOR;

EID: 0031965717     PISSN: 0016867X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (14)

1. Uitti RJ. Tremor: How to determine if the patient has Parkinson's disease. Geriatrics 1998; 53(May):30-6.
2. Rajput AH, Rozdilsky B, Rajput A. Accuracy of clinical diagnosis in parkinsonism - a prospective study. Can J Neurol Sci 1991; 18:275-8.
3. Koller WC, Hubble JP, Busenbark KL. Essential tremor. In: Calne DB (ed). Neurodegenerative diseases. Philadelphia: W.B. Saunders, 1994:717-42.
4. Olanow CW, Koller WC. An algorithm (decision tree) for the management of Parkinson's disease: Treatment guidelines. Neurology 1998; 50(suppl 3):S1-S57.
5. Block G, Liss C, Reines S, Irr J, Nibbelink D. Comparison of immediate-release and controlled-release carbidopa/levodopa in Parkinson's disease: A multicenter 5-year study. Eur Neurol 1997; 37:23-37.
6. Ahlskog JE. Treatment of early Parkinson's disease: Are complicated strategies justified? Mayo Clinic Proc 1996; 71:659-70.
7. Uitti RJ, Ahlskog JE. Comparative review of dopamine receptor agonists in Parkinson's disease. CNS Drugs 1996; 5:369-88.
8. Rajput AH, Martin W, Saint-Hilaire M, Dorflinger E, Pedder S. Tolcapone improves motor function in parkinsonian patients with the "wearing off" phenomenon: A double-blind, placebo-controlled, multicenter trial. Neurology 1997; 49:1066-71.
9. Parkinson Study Group. Entacapone improves motor fluctuations in levodopa-treated Parkinson's disease patients. Ann Neurol 1997; 42:747-55.
10. Limousin P, Pollak P, Benazzouz A, et al. Effect on parkinsonian signs and symptoms of bilateral subthalamic nucleus stimulation. Lancet 1995; 345:91-5.
11. Shannon KM, Bennett JP, Friedman JH. Efficacy of pramipexole, a novel dopamine agonist, as monotherapy in mild to moderate Parkinson's disease. The Pramipexole Study Group. Neurology 1997; 49:724-8.
12. Lieberman A, Ranhosky A, Korts D. Clinical evaluation of pramipexole in advanced Parkinson's disease: Results of a double-blind, placebo-controlled, parallel-group study. Neurology 1997; 49:162-8.
13. Rascol O, Lees AJ, Senard JM, Pirtosek Z, Montastruc JL, Fuell D. Ropinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease. Clin Neuropharmacol 1996; 19:234-45.
14. Uitti RJ, Wharen RE, Turk MF, et al. Unilateral pallidotomy for Parkinson's disease: Comparison of outcome in younger versus elderly patients. Neurology 1997; 49:1072-7.